SCHEMBL1633031

SCHEMBL1633031

CN1CCN(Cc2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 1/20 0.47
▸ CDK2 P24941 4/20 0.47
▸ CCNE1 P24864 3/20 0.47
▸ IKBKB O14920 3/20 0.47
▸ AXL P30530 2/20 0.46
▸ CCNT1 O60563 3/20 0.46
▸ CDK1 P06493 3/20 0.46
▸ CCNB1 P14635 3/20 0.46
▸ CDK9 P50750 3/20 0.46
▸ STK4 Q13043 3/20 0.46
▸ CCNB2 O95067 2/20 0.46
▸ CCNE2 O96020 2/20 0.46
▸ CDK5 Q00535 2/20 0.46
▸ CDK5R1 Q15078 2/20 0.46
▸ CCNB3 Q8WWL7 2/20 0.46
▸ CA2 P00918 2/20 0.45
▸ FGFR1 P11362 1/20 0.45
▸ AURKA O14965 2/20 0.45
▸ NUAK1 O60285 1/20 0.45
▸ STK16 O75716 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633835 0.91 IKBKB (0.47) CDK2CCNE1IKBKBCCNT1CDK1
SCHEMBL1632154 0.89 CDK2 (0.46) CDK2CCNE1IKBKBCCNT1CDK1
SCHEMBL1631354 0.89 TYK2 (0.54) CDK2CCNE1IKBKBCCNT1CDK1
SCHEMBL1632397 0.88 TBK1 (0.57) CDK2IKBKBCCNT1CDK1CCNB1
SCHEMBL1633063 0.85 IKBKB (0.53) CDK2CCNE1IKBKBCCNT1CDK1
SCHEMBL1632055 0.85 CCNE1 (0.46) CDK2CCNE1IKBKBCCNT1CDK1
SCHEMBL1633709 0.84 SYK (0.47) CDK2CCNE1IKBKBCCNT1CDK1
SCHEMBL1633524 0.83 JAK2 (0.50) FGFR4IKBKBAXLFGFR1NUAK1
SCHEMBL1633354 0.82 CDK1 (0.44) FGFR4CDK2IKBKBCDK1CDK9
SCHEMBL1633356 0.82 CDK1 (0.44) FGFR4CDK2IKBKBCDK1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback